Skip to main content
Premium Trial:

Request an Annual Quote

Alex Dickinson, Robert Proulx

Alex Dickinson and Robert Proulx have joined the board of directors of Quantapore.

Dickinson is the founder and executive chairman of molecular diagnostics firm ChromaCode. Previously, he was a senior vice president at Illumina, and prior to that, the founder and CEO of molecular diagnostics firm Helixis, which Illumina acquired in 2010. Earlier, he was the founder and CEO of Luxtera, which provides silicon photonics products. Dickinson holds a PhD from the University of Adelaide in Australia and an MBA from Columbia University.

Proulx is executive chairman and CEO of Imagion Biosystems, a medical imaging company. Previously, he was the president of Silicon Biosystems, which was acquired by the Menarini Group. He also held executive positions at Nanogen, Gene Logic, Igen, and Packard Bioscience. Proulx holds MA and BA degrees from the State University of New York at Albany and an executive MBA from the Penn State Smeal College of Business.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.